Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study

Behçet disease (BD) is a multisystem disease associated with a poor prognosis in cases of gastrointestinal, neurological, or vascular involvement. We conducted a multicenter, prospective, open-label, single-arm phase 3 study to determine the efficacy, safety, and pharmacokinetics of infliximab (IFX)...

Full description

Bibliographic Details
Main Authors: Hibi, Toshifumi, Hirohata, Shunsei, Kikuchi, Hirotoshi, Tateishi, Ukihide, Sato, Noriko, Ozaki, Kunihiko, Kondo, Kazuoki, Ishigatsubo, Yoshiaki
Format: Online
Language:English
Published: Wolters Kluwer Health 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998455/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998455/

Similar Items